Hot-selling Imatinib Mesylate - Canagliflozin Hemihydrate CAS 928672-86-0 Purity ≥99.0% (HPLC) T2DM API High Purity – Ruifu

Short Description:

Product Detail

Product Tags

Feedback (2)

Reliable good quality and very good credit standing are our principles, which will help us at a top-ranking position. Adhering to your tenet of "quality 1st, purchaser supreme" for 56-41-7, 1-(4-(Benzyloxy)-3-nitrophenyl)-2-bromoethanone, N-(4-Carboxyphenyl)Guanidine Hydrochloride, All the time, we have been paying attention on all details to insure each product satisfied by our customers.

Hot-selling Imatinib Mesylate - Canagliflozin Hemihydrate CAS 928672-86-0 Purity ≥99.0% (HPLC) T2DM API High Purity – Ruifu Detail:

Chemical Name	Canagliflozin Hemihydrate
CAS Number	928672-86-0
CAT Number	RF-API22
Stock Status	In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula	C24H27FO6S
Molecular Weight	462.53
Brand	Ruifu Chemical

Item	Specifications
Appearance	White Powder
Identification	HPLC/NMR
Solubility	Very Soluble in methanol; Soluble in ethanol, acetonitrile; Slightly soluble in water
Purity / Analysis Method	≥99.0% (HPLC)
Individual Impurity	≤0.10%
Total Impurities	≤0.50%
Residual Solvents
Methanol	≤3000ppm
Ethanol	≤5000ppm
Acetonitrile	≤400ppm
Dichloromethane	≤600ppm
Ethyl Acetate	≤5000ppm
THF	≤720ppm
Toluene	≤890ppm
Test Standard	Chinese Pharmacopoeia (CP); Enterprise Standard
Usage	Active Pharmaceutical Ingredient (API); SGLT-2 inhibitors Type 2 Diabetes

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Canagliflozin is a drug of the gliflozin class or subtype 2 sodium-glucose transport inhibitors (SGLT2) used for the treatment of type 2 diabetes. It was developed by Mitsubishi Tanabe Pharma and is marketed under license by Janssen, a division of Johnson & Johnson. Canagliflozin is responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter causes blood glucose to be eliminated through the urine. In March 2013, canagliflozin became the first SGLT2 inhibitor to be approved in the United States.

Canagliflozin, to mention the advantage, this drug helps patients to reduce blood sugars without increasing the likelihood of gaining weight as long as a healthy, balanced diet is followed and regular exercise taken. In addition, Canagliflozin has a broad prospect due to its significant antiobesity effects and few hypoglycemic events.

Product detail pictures:

Related Product Guide:

Innovation, good quality and reliability are the core values of our enterprise. These principles today extra than ever form the basis of our success as an internationally active mid-size organization for Hot-selling Imatinib Mesylate - Canagliflozin Hemihydrate CAS 928672-86-0 Purity ≥99.0% (HPLC) T2DM API High Purity – Ruifu , The product will supply to all over the world, such as: United Kingdom, Turkey, US, Should any of these items be of interest to you, please let us know. We'll be satisfied to give you a quotation upon receipt of one's detailed specifications. We have our personal experienced R&D enginners to meet any of one's requriements, We appear forward to receiving your enquires soon'and hope to have the opportunity to work together with you in the future. Welcome to check out our company.